Navigation Links
PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
Date:5/23/2011

PRINCETON, N.J., May 23, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that its experts will be sharing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at the ASMS 59th Conference on Mass Spectrometry and Allied Topics in Denver, Colorado from June 5 to June 9. PharmaNet's scientists welcome you to attend their poster sessions throughout the conference.Tuesday June 7Poster 255: On-Cartridge Derivatization for the Determination of Bisphosphonates in Human UrineAuthors: Nicolas Jean, Sylvain Lachance, Nadine Boudreau, Sofi Gagnon-Carignan, Ann LevesquePoster 277: Stability issues and method development of a polar phenolic quaternary amine compound in human plasma by LC/MS/MSAuthors: Valerie Montminy, Nicolas Piquet, Sylvain Lachance, Nadine Boudreau; Ann LevesquePoster 257: Using ICP-MS Detection for Determination of Bismuth in Human Blood and Plasma SamplesAuthors: Nadia Savard, Sebastien Gagne, Francois Viel, Brigitte Pellerin, Nadine BoudreauPoster 258: High Throughput Analysis of Biological Samples Containing Trace Metals with Limited Down Time by ICP-MSAuthors: Sebastien Gagne, Francois Viel, Nadine Boudreau, Sylvain Lachance, Sofi Gagnon-Carignan, Ann LevesquePoster 267: Development and Validation of a Dried Blood Spot Assay for the Determination of Midazolam in Human Whole Blood by LC/MS/MSAuthors: Guy Havard, Marie-Claude Theberge, Nadine Boudreau, Ann LevesquePoster 273: Ultra Low Picograms Determination of a Glucocorticoid in Human PlasmaAuthors: Nadia Smith, Nicolas Jean, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 272: An Ultrasensitive LC/MS/MS Method for the Determination of Formoterol in Human Plasma at Femtogram LevelAuthors: Isabelle M. Levesque, Francois Viel, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 271: Evaluation of Hemolysis Effect during Sample Collection and Handling to Mimic Incurred Samples during LC/MS/MS Method ValidationAuthors: Sebastien Gagne, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 268: Analyte and Internal Standard Cross Signal Contributions in Mass Spectrometric Detection and Their Impact on the Quantitation by LC/MSAuthors: Aimin Tan, Isabelle A. Levesque, Isabelle M. Levesque, Francois Viel, Nadine Boudreau, Ann LevesquePoster 269: A Novel Automated LCMSMS Method for the Simultaneous Determination of Levothyroxine (T4) and Liothyronine (T3) in Human SerumAuthors: Gilles Provencher, Francois Viel, Nadine Boudreau, Ann LevesquePoster 270: LC/MS/MS Analysis of Doxercalciferol and its Main Metabilite in Human Plasma at Low Picogram LevelAuthors: Guy Havard, Sylvain Lachance, Nadine Boudreau, Ann LevesqueWednesday June 8Poster 146: A Robust and Selective Method for Two Omega-3 Fatty Acids (Eicosapentanoic Acid and Docosahexaenoic Acid) in Several Matrix SpeciesAuthors: Guy Havard, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann Levesque, Farhad Amiri, Bruno Battistini, Tina SampalisThursday June 9Poster 469: Determination of Polypeptides and other Large Molecular Weight Molecules by LC/MS/MSAuthors: Genevieve Emond, Nadia Savard, Simon Bedard, Philippe Belanger, Nancy Lampron, Nathalie Pelletier, Marie-Josee Marcoux, Sylvain Lachance, Nadine Boudreau, Ann LevesqueAbout PharmaNet PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact:  Anne-Marie Hess
Phone:   (609) 951-6842
E-mail:   ahess@pharmanet.com


'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. JLL Partners Sells PharmaNet
2. inVentiv Health to Acquire PharmaNet
3. Valerie Palumbo Joins PharmaNet as Senior Vice President, Corporate Quality Assurance
4. PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference
5. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
6. PharmaNet and Anapharm Europe Formally End Joint Venture
7. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
8. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
9. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
10. PharmaNet Development Group Announces Observational Research Survey
11. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):